Kevin J. O'Connor
Kevin J. O'Connor's purchase track record
Kevin J. O'Connor has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/6/2022 | EHC | $66K | +1.7% | +5.4% | -8.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
LMT receives C-130J-30 delivery for Navy. The U.S. Navy has taken delivery of a C-130J-30 Super Hercules, which will serve as the future TACAMO communications platform and includes the E-130J Phoenix II variant. The delivery highlights ongoing demand for Lockheed Martin's transport aircraft and supports its defense contract pipeline. A recent dividend increase for the company adds to the positive earnings backdrop.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Carrier Global Sees Mixed Analyst Actions with Target Cuts, Downgrade. Carrier Global saw mixed analyst actions, including a downgrade to Neutral by Goldman Sachs with a $61 target, while Mizuho and RBC Capital maintained Outperform ratings with lowered targets of $70 and $72. These revisions reflect a cautious stance as the average analyst target of $73.66 remains above current levels. The stock trades within a 52-week range of $50.24 to $76.76.
Transaction History
| EHC | ▲ Buy | Grant | 19 | $0 | 7/15/2026 | View on chart |
| EHC | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 | View on chart |
| EHC | ▲ Buy | Grant | 17 | $0 | 4/15/2026 | View on chart |
| LMT | ▲ Buy | Option Exercise | 5,285 | $0 | 2/26/2026 | View on chart |
| LMT | ▼ Sell | Tax Withholding | 2,566 | $1.6M | 2/26/2026 | View on chart |
| EHC | ▲ Buy | Grant | 17 | $0 | 1/15/2026 | View on chart |
| EHC | ▲ Buy | Grant | 14 | $0 | 10/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 15 | $0 | 7/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 | View on chart |
| EHC | ▲ Buy | Grant | 13 | $0 | 4/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 14 | $0 | 1/15/2025 | View on chart |
| CARR | ▲ Buy | Option Exercise | 217,150 | $5.6M | 11/6/2024 | View on chart |
| CARR | ▼ Sell | Tax Withholding | 81,967 | $6.1M | 11/6/2024 | View on chart |
| CARR | ▼ Sell | Open Market | 167,183 | $12.3M | 11/6/2024 | View on chart |
| CARR | ▲ Buy | Option Exercise | 32,000 | $530K | 11/6/2024 | View on chart |
| EHC | ▲ Buy | Grant | 14 | $0 | 10/15/2024 | View on chart |
| EHC | ▲ Buy | Grant | 13 | $0 | 7/15/2024 | View on chart |
| CARR | ▼ Sell | Open Market | 20,000 | $1.3M | 5/16/2024 | View on chart |
| EHC | ▲ Buy | Grant | 1,978 | $0 | 5/2/2024 | View on chart |
| EHC | ▲ Buy | Grant | 11 | $0 | 4/15/2024 | View on chart |
| CARR | ▼ Sell | Open Market | 26,551 | $1.4M | 2/8/2024 | View on chart |
| CARR | ▲ Buy | Grant | 39,836 | $0 | 2/4/2024 | View on chart |
| CARR | ▼ Sell | Tax Withholding | 13,285 | $754K | 2/4/2024 | View on chart |
| EHC | ▲ Buy | Grant | 12 | $0 | 1/16/2024 | View on chart |
| EHC | ▲ Buy | Grant | 13 | $0 | 10/16/2023 | View on chart |
| EHC | ▲ Buy | Grant | 12 | $0 | 7/17/2023 | View on chart |
| CARR | ▼ Sell | Open Market | 21,049 | $866K | 5/26/2023 | View on chart |
| CARR | ▲ Buy | Grant | 61,660 | $0 | 5/16/2023 | View on chart |
| CARR | ▼ Sell | Tax Withholding | 24,264 | $1.0M | 5/16/2023 | View on chart |
| EHC | ▲ Buy | Grant | 2,385 | $0 | 5/4/2023 | View on chart |
| EHC | ▲ Buy | Grant | 8 | $0 | 4/17/2023 | View on chart |
| CARR | ▲ Buy | Option Exercise | 167 | $0 | 2/10/2023 | View on chart |
| CARR | ▼ Sell | Tax Withholding | 57 | $3K | 2/10/2023 | View on chart |
| CARR | ▼ Sell | Tax Withholding | 66 | $3K | 2/10/2023 | View on chart |
| CARR | ▲ Buy | Option Exercise | 143 | $0 | 2/10/2023 | View on chart |
| CARR | ▲ Buy | Option Exercise | 34,706 | $0 | 2/4/2023 | View on chart |
| CARR | ▼ Sell | Tax Withholding | 21,049 | $987K | 2/4/2023 | View on chart |
| EHC | ▲ Buy | Grant | 8 | $0 | 1/17/2023 | View on chart |
| CARR | ▲ Buy | Option Exercise | 40,471 | $0 | 1/2/2023 | View on chart |
| CARR | ▼ Sell | Tax Withholding | 12,487 | $515K | 1/2/2023 | View on chart |
| EHC | ▲ Buy | Grant | 10 | $0 | 10/17/2022 | View on chart |
| EHC | ▲ Buy | Grant | 17 | $0 | 7/20/2022 | View on chart |
| EHC | ▲ Buy | Open Market | 1,000 | $66K | 5/6/2022 | View on chart |
| EHC | ▲ Buy | Grant | 2,226 | $0 | 5/5/2022 | View on chart |
| EHC | ▲ Buy | Grant | 1 | $0 | 4/18/2022 | View on chart |
| EHC | ▲ Buy | Grant | 209 | $0 | 3/30/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.